SEI Investments
ABEO icon

SEI Investments’s Abeona Therapeutics ABEO Stock Holding History

SEI Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$593K Buy
112,995
+7,435
+7% +$46.2K ﹤0.01% 2566
2026
Q2 		$652K Sell
105,560
-66,900
-39% -$367K ﹤0.01% 2525
2026
Q1 		$773K Buy
172,460
+101,307
+142% +$506K ﹤0.01% 2478
2025
Q4 		$375K Buy
+71,153
New +$358K ﹤0.01% 2632

Other funds holding ABEO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nan Fung Trinity
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

SEI Investments's ABEO Position: Q3 2026 in Review

SEI Investments increased its Abeona Therapeutics (ABEO) stake by 7% in Q3 2026, buying an estimated $46.2K and bringing the position to 112,995 shares worth $593K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

SEI Investments first reported a position in ABEO in Q4 2025 and has held it in 4 quarters since. The position peaked at $773K in Q1 2026. 42 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

  • SEI Investments held 112,995 shares of Abeona Therapeutics worth $593K as of Q3 2026.
  • SEI Investments bought 7,435 Abeona Therapeutics shares in Q3 2026, an estimated $46.2K.
  • Abeona Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2566 holding.
  • SEI Investments first reported a position in Abeona Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • SEI Investments's Abeona Therapeutics position peaked at $773K in Q1 2026.
  • 42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.